Jiangxi Fushine Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Jiangxi Fushine Pharmaceutical Co Ltd cash flow-to-debt ratio. Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥18.31 Million could theoretically repay 0% of its total liabilities (CN¥2.27 Billion) in one year. Check 300497 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)
Cash flow-to-debt ratio of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. Historical debt coverage capacity for Jiangxi Fushine Pharmaceutical Co Ltd across 15 annual periods. Check Jiangxi Fushine Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Jiangxi Fushine Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2011–2025)
Jiangxi Fushine Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Jiangxi Fushine Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 300497 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | CN¥62.67 Million | CN¥2.20 Billion | ▼ -64.2% |
| 2024 | 0.08x | CN¥187.64 Million | CN¥2.36 Billion | ▲ +388.3% |
| 2023 | -0.03x | CN¥-64.76 Million | CN¥2.35 Billion | ▲ +45.9% |
| 2022 | -0.05x | CN¥-120.85 Million | CN¥2.37 Billion | ▼ -224.6% |
| 2021 | 0.04x | CN¥72.32 Million | CN¥1.77 Billion | ▼ -89.3% |
| 2020 | 0.38x | CN¥382.35 Million | CN¥997.93 Million | ▲ +21.1% |
| 2019 | 0.32x | CN¥337.91 Million | CN¥1.07 Billion | ▲ +88.8% |
| 2018 | 0.17x | CN¥175.91 Million | CN¥1.05 Billion | ▼ -34.6% |
| 2017 | 0.26x | CN¥210.72 Million | CN¥822.70 Million | ▼ -16.6% |
| 2016 | 0.31x | CN¥188.53 Million | CN¥614.20 Million | ▲ +71.5% |
| 2015 | 0.18x | CN¥74.01 Million | CN¥413.44 Million | ▲ +99.1% |
| 2014 | 0.09x | CN¥31.39 Million | CN¥349.09 Million | ▼ -51.0% |
| 2013 | 0.18x | CN¥57.22 Million | CN¥311.55 Million | ▼ -15.2% |
| 2012 | 0.22x | CN¥63.20 Million | CN¥291.70 Million | ▲ +48.7% |
| 2011 | 0.15x | CN¥33.80 Million | CN¥232.04 Million | — |